July 1, 2021 Does new Alzheimer's drug work? Answers may miss 2030 target When a controversial Alzheimer’s drug won U.S. approval, surprise over the decision quickly turned to shock at how long it might take to find out if it really works — nine years.
June 27, 2021 Alzheimer's drug stirs hope for patients, worry for doctors In the weeks since a new Alzheimer’s drug was approved, hopeful patients have bombarded Dr. Alireza Atri with calls and emails about a treatment that has sparked both excitement and skepticism.
June 21, 2021 FDA adviser who resigned over Alzheimer's drug says 'no good evidence' it works One of the FDA advisory panel members who resigned after the agency granted Biogen’s Alzheimer’s drug Accelerated Approval has said "the drug showed no good evidence that it worked."
June 19, 2021 Virginia man to row 24 hours straight to raise awareness, funds for Alzheimer's association A Virginia man is raising awareness of Alzheimer’s disease by rowing for 24 hours straight – possibly setting a world record in the process.
June 16, 2021 Biogen's debated Alzheimer's drug given to first patient A Rhode Island man became the first patient worldwide to receive Biogen’s hotly debated Alzheimer’s drug outside of a clinical trial on Wednesday, a hospital spokesperson confirmed to Fox News.
June 15, 2021 New treatment slows Alzheimer’s progression in monkeys, researchers claim A new treatment triggered immune cells to clear out toxic plaque buildup and slow progression of Alzheimer’s disease in monkeys, researchers claim.
June 10, 2021 2 FDA committee members resign over Biogen Alzheimer's drug approval Fallout over the FDA’s recent decision to grant Biogen’s Alzheimer’s drug accelerated approval has seen two advisory panel members resign.
June 8, 2021 Dr. Howard Fillit: Why Alzheimer's milestone, new research gives me hope for millions of patients and families Many patient advocacy groups representing the 6 million Americans suffering from Alzheimer’s disease are hailing the FDA’s approval of a new treatment for Alzheimer’s, aducanamab – the first since 2003.
June 8, 2021 Who should take new Alzheimer's drug? Expert weighs in After the Food and Drug Administration granted approval to the first Alzheimer’s drug in nearly two decades, Biogen's Aduhelm (aducanumab), doctors are left triaging patient calls in a bid to find the appropriate patient with a mild, early course of disease.
June 8, 2021 FDA OK's Biogen's Alzheimer's drug: What is Accelerated Approval? The Food and Drug Administration on Monday approved Biogen’s Alzheimer’s drug albeit to mixed reviews.
